Supporting CDISC Adoption Across the NCI Community

September 12, 2022 Westat expertise in is on hand at the 24th SCDM Annual Conference, held September 11-14, 2022, in San Antonio, Texas. The conference is considered the world’s leading clinical data management (CDM) conference, providing the opportunity for CDM knowledge sharing and education. Westat’s Ginger Riley and coauthor Neesha Desai will present : Adoption … Read more

Clinical Trials Site Monitoring Expertise at 2022 SOCRA

September 12, 2022 Westat site monitoring expertise will be spotlighted in 2 posters at the 31st Annual SOCRA Conference, which will be held virtually September 14-17, 2022. The conference enables the global clinical research community to come together and work toward safe, efficient, and quality clinical research. Isabel Trejos and Silvia Jimenez are presenting a poster about … Read more

Lauren Laimon on 2022 Top 50 Women Leaders of Maryland

View Lauren Laimon profile.

July 28, 2022 Lauren Laimon, M.S., a Westat Senior Study Director for Clinical Trials, has been selected as one of the 2022 Top 50 Women Leaders of Maryland by Women We Admire. The organization provides news and information on today’s women leaders in the state, recognizing the achievements of exceptional women and their dedication to … Read more

First Patient Enrolled in HIV Combination Maintenance Therapy Study

Read more on First Patient Enrolled in HIV Combination Maintenance Therapy Study

July 29, 2022 Built on a long-standing partnership with TaiMed Biologics, Inc., (TaiMed), Westat and TaiMed have announced the first patient has been enrolled in the new TMB-a21 study. TMB-a21 is a Phase 1b/2a study involving HIV-1 infected patients who are virally suppressed. The investigational products, TMB-365 and TMB-380, are monoclonal antibodies administered together via … Read more

New Screening Tool Helps Identify Barriers to Patients Joining Clinical Trials

March 2, 2021 Increasing patient enrollment to clinical trials continues to be challenging despite efforts to identify multiple physician, patient, and system barriers. One way to alleviate this problem is to expand demographic and comorbidity data collection. This additional information can then enhance our understanding of the barriers, develop interventions to overcome them, and recognize … Read more

Protecting Pregnant Women with HIV and Their Infants Against Pneumococcus

April 29, 2021 Pneumococcus is a significant danger to pregnant women with HIV and their infants. PCV-10 and PPV-23 are 2 vaccines that help protect against invasive disease like pneumococcus. New research has compared the safety and immunogenicity of PCV-10 and PPV-23 administered in pregnancy. In a new article published in the Lancet, Westat’s Lauren Laimon, M.S., … Read more

First Next-Generation Freeze-Dried Plasma (FDP) Product Found to Be as Safe and Potent as Fresh Frozen Plasma (FFP)

January 6, 2022 Data from a phase 1 dose-escalation trial reveals that a first next-generation freeze-dried plasma (FDP) product retains the same potency and safety of fresh frozen plasma (FFP). Manufactured in a rugged plastic container, FDP provides readily accessible plasma for rapid transfusion in therapeutic resuscitation protocols for acute traumatic hemorrhage. The research results … Read more

Westat CLS—Showcasing CRO Services to Commercial Clients

November 10, 2021 Biopharmaceutical industry clients now have direct access to Westat’s clinical contract research organization (CRO) services and expertise through a new portal: Westat Commercial Life Sciences (Westat CLS). “The website showcases our strengths in all areas of clinical trials support so that current and new clients and partners can appreciate how we will work … Read more